Opioid Analgesics and Nicotine: More Than Blowing Smoke

REFERENCES

• Centers for Disease Control and Prevention. Current cigarette smoking among adults—United States, 2005–2012. MMWR Morb Mort Wkly Rep. 2014;63:29–34.
   PubMed Web of Science ®Google Scholar
• Boudreau D, Von Korff M, Rutter CM, et al. Trends in long-term opioid therapy for chronic non-cancer pain. Pharmacoepidemiol Drug Saf. 2009;18:1166–1175.
   PubMed Web of Science ®Google Scholar
• Rogal SS, Winger D, Bielefeldt K, Szigethy E. Pain and opioid use in chronic liver disease. Digest Dis Sci. 2013;58:2976–2985.
   PubMed Web of Science ®Google Scholar
• Dobscha SK, Morasco BJ, Duckart JP, Macey T, Deyo RA. Correlates of prescription opioid initiation and long-term opioid use in veterans with persistent pain. Clin J Pain. 2013;29:102–108.
   PubMed Web of Science ®Google Scholar
• Qiu YM, Liu YT, Li ST. Tramadol requirements may need to be increased for the perioperative management of pain in smokers. Med Hypotheses. 2011;77:1071–1073.
   PubMed Web of Science ®Google Scholar
• Steinmiller CL, Diederichs C, Roehrs TA, Hyde-Nolan M, Roth T, Greenwald MK. Postsurgical patient-controlled opioid self-administration is greater in hospitalized abstinent smokers than nonsmokers. J Opioid Manage. 2012;8:227–235.
   PubMedGoogle Scholar
• Ackerman WE 3rd. The effect of cigarette smoking on hydrocodone efficacy in chronic pain patients. J Ark Med Soc. 2012;109:90–93.
   PubMedGoogle Scholar
• Scott SC, Goldberg MS, Mayo NE, Stock SR, Poitras B. The association between cigarette smoking and back pain in adults. Spine. 1999;24:1090–1098.
   PubMed Web of Science ®Google Scholar
• Palmer KT, Syddall H, Cooper C, Coggon D. Smoking and musculoskeletal disorders: findings from a British national survey. Ann Rheum Dis. 2003;62:33–36.
   PubMed Web of Science ®Google Scholar
• Shi Y, Weingarten TN, Mantilla CB, Hooten WM, Warner DO. Smoking and pain: pathophysiology and clinical implications. Anesthesiology. 2010;113:977–992.
   PubMed Web of Science ®Google Scholar
• John U, Alte D, Hanke M, Meyer C, Volzke H, Schumann A. Tobacco smoking in relation to analgesic drug use in a national adult population sample. Drug Alcohol Depend. 2006;85:49–55.
   PubMed Web of Science ®Google Scholar
• Mikkonen P, Leino-Arjas P, Remes J, Zitting P, Taimela S, Karppinen J. Is smoking a risk factor for low back pain in adolescents? A prospective cohort study. Spine. 2008;33:527–532.
   PubMed Web of Science ®Google Scholar
• Hestbaek L, Leboeuf-Yde C, Kyvik KO. Are lifestyle-factors in adolescence predictors for adult low back pain? A cross-sectional and prospective study of young twins. BMC Musculoskelet Disord. 2006;7:27.
   PubMed Web of Science ®Google Scholar
• Mattila VM, Saarni L, Parkkari J, Koivusilta L, Rimpela A. Predictors of low back pain hospitalization—a prospective follow-up of 57,408 adolescents. Pain. 2008;139:209–217.
   PubMed Web of Science ®Google Scholar
• Weingarten TN, Podduturu VR, Hooten WM, Thompson JM, Luedtke CA, Oh TH. Impact of tobacco use in patients presenting to a multidisciplinary outpatient treatment program for fibromyalgia. Clin J Pain. 2009;25:39–43.
   PubMed Web of Science ®Google Scholar
• Weingarten TN, Sprung J, Flores A, Baena AM, Schroeder DR, Warner DO. Opioid requirements after laparoscopic bariatric surgery. Obes Surg. 2011;21:1407–1412.
   PubMed Web of Science ®Google Scholar
• Hagen KB, Tambs K, Bjerkedal T. A prospective cohort study of risk factors for disability retirement because of back pain in the general working population. Spine. 2002;27:1790–1796.
   PubMed Web of Science ®Google Scholar
• Lincoln AE, Smith GS, Amoroso PJ, Bell NS. The natural history and risk factors of musculoskeletal conditions resulting in disability among US Army personnel. Work. 2002;18:99–113.
   PubMedGoogle Scholar
• Guydish J, Passalacqua E, Tajima B, Chan M, Chun J, Bostrom A. Smoking prevalence in addiction treatment: a review. Nicotine Tob Res. 2011;13:401–411.
   PubMed Web of Science ®Google Scholar
• Zirakzadeh A, Shuman C, Stauter E, Hays JT, Ebbert JO. Cigarette smoking in methadone maintained patients: an up-to-date review. Curr Drug Abuse Rev. 2013;6:77–84.
   PubMedGoogle Scholar
• Pajusco B, Chiamulera C, Quaglio G, et al. Tobacco addiction and smoking status in heroin addicts under methadone vs. buprenorphine therapy. Int J Environ Res Public Health. 2012;9:932–942.
   PubMed Web of Science ®Google Scholar
• Li L, Liu Y, Zhang Y, Beveridge TJ, Zhou W. Temporal changes of smoking status and motivation among Chinese heroin-dependent, methadone-maintained smokers. Addict Behav. 2010;35:861–865.
   PubMed Web of Science ®Google Scholar
• Richter KP, Ahluwalia JS. A case for addressing cigarette use in methadone and other opioid treatment programs. J Addict Dis. 2000;19:35–52.
   PubMed Web of Science ®Google Scholar
• Okoli CT, Khara M, Procyshyn RM, Johnson JL, Barr AM, Greaves L. Smoking cessation interventions among individuals in methadone maintenance: a brief review. J Subst Abuse Treat. 2010;38:191–199.
   PubMed Web of Science ®Google Scholar
• Skurtveit S, Furu K, Selmer R, Handal M, Tverdal A. Nicotine dependence predicts repeated use of prescribed opioids. Prospective population-based cohort study. Ann Epidemiol. 2010;20:890–897.
   PubMed Web of Science ®Google Scholar
• David SP, Chu IM, Lancaster T, Stead LF, Evins AE, Prochaska JJ. Systematic review and meta-analysis of opioid antagonists for smoking cessation. BMJ Open. 2014;4:e004393.
   PubMed Web of Science ®Google Scholar
• Kishioka S, Kiguchi N, Kobayashi Y, Saika F. Nicotine effects and the endogenous opioid system. J Pharmacol Sci. 2014;125:117–124.
   PubMed Web of Science ®Google Scholar
• Xue Y, Domino EF. Tobacco/nicotine and endogenous brain opioids. Prog Neuropsychopharmacol Biol Psychiatry. 2008;32:1131–1138.
   PubMed Web of Science ®Google Scholar
• Ekholm O, Gronbaek M, Peuckmann V, Sjogren P. Alcohol and smoking behavior in chronic pain patients: the role of opioids. Eur J Pain. 2009;13:606–612.
   PubMed Web of Science ®Google Scholar
• Mishriky BM, Habib AS. Nicotine for postoperative analgesia: a systematic review and meta-analysis. Anesth Analg. 2014;119:268–275.
   PubMed Web of Science ®Google Scholar
• Wee S, Koob GF. The role of the dynorphin-kappa opioid system in the reinforcing effects of drugs of abuse. Psychopharmacology. 2010;210:121–135.
   PubMed Web of Science ®Google Scholar
• Berrendero F, Robledo P, Trigo JM, Martin-Garcia E, Maldonado R. Neurobiological mechanisms involved in nicotine dependence and reward: participation of the endogenous opioid system. Neurosci Biobehav Rev. 2010;35:220–231.
   PubMed Web of Science ®Google Scholar
• Hadjiconstantinou M, Neff NH. Nicotine and endogenous opioids: neurochemical and pharmacological evidence. Neuropharmacology. 2011;60:1209–1220.
   PubMed Web of Science ®Google Scholar
• Benarroch EE. GABAB receptors: structure, functions, and clinical implications. Neurology. 2012;78:578–584.
   PubMed Web of Science ®Google Scholar
• Talka R, Salminen O, Whiteaker P, Lukas RJ, Tuominen RK. Nicotine-morphine interactions at alpha4beta2, alpha7 and alpha3() nicotinic acetylcholine receptors. Eur J Pharmacol. 2013;701:57–64.
   PubMed Web of Science ®Google Scholar
• Garland EL, Froeliger B, Zeidan F, Partin K, Howard MO. The downward spiral of chronic pain, prescription opioid misuse, and addiction: cognitive, affective, and neuropsychopharmacologic pathways. Neurosci Biobehav Rev. 2013;37( 10 Pt 2):2597–2607.
   PubMed Web of Science ®Google Scholar
• Tuesta LM, Fowler CD, Kenny PJ. Recent advances in understanding nicotinic receptor signaling mechanisms that regulate drug self-administration behavior. Biochem Pharmacol. 2011;82:984–995.
   PubMed Web of Science ®Google Scholar
• Classification of chronic pain. Descriptions of chronic pain syndromes and definitions of pain terms. Prepared by the International Association for the Study of Pain, Subcommittee on Taxonomy. Pain Suppl. 1986;3:S1–S226.
   Google Scholar
• Institute of Medicine. Relieving Pain in America: A Blueprint for Transforming Prevention, Care, Education, and Research. Washington, DC: National Academies Press; 2011.
   Google Scholar
• Feinberg S, Christian J, Feinberg R, Kalauokalani D, Pasero C, Phol M. ACPA Resource Guide to Chronic Pain Medication & Treatment. Rocklin, CA: American Chronic Pain Association; 2015.
   Google Scholar
• Kalman D, Morissette SB, George TP. Co-morbidity of smoking in patients with psychiatric and substance use disorders. Am J Addict. 2005;14:106–123.
   PubMed Web of Science ®Google Scholar
• Patkar AA, Mannelli P, Peindl K, Murray HW, Meier B, Leone FT. Changes in tobacco smoking following treatment for cocaine dependence. Am J Drug Alcohol Abuse. 2006;32:135–148.
   PubMed Web of Science ®Google Scholar
• Gudin J. Opioid therapies and cytochrome P450 interactions. J Pain Symptom Manage. 2012;44(6 Suppl):S4–S14.
   PubMed Web of Science ®Google Scholar
• Wilkinson GR. Drug metabolism and variability among patients in drug response. New Engl J Med. 2005;352:2211–2221.
   PubMed Web of Science ®Google Scholar
• Kadiev E, Patel V, Rad P, et al. Role of pharmacogenetics in variable response to drugs: focus on opioids. Exp Opin Drug Metab Toxicol. 2008;4:77–91.
   PubMed Web of Science ®Google Scholar
• Rogers JF, Nafziger AN, Bertino JS Jr. Pharmacogenetics affects dosing, efficacy, and toxicity of cytochrome P450-metabolized drugs. Am J Med. 2002;113:746–750.
   PubMed Web of Science ®Google Scholar
• Bertilsson L, Lou YQ, Du YL, et al. Pronounced differences between native Chinese and Swedish populations in the polymorphic hydroxylations of debrisoquin and S-mephenytoin. Clin Pharmacol Ther. 1992;51:388–397.
   PubMed Web of Science ®Google Scholar
• Johansson I, Ingelman-Sundberg M. Genetic polymorphism and toxicology—with emphasis on cytochrome P450. Toxicol Sci. 2011;120:1–13.
   PubMed Web of Science ®Google Scholar
• Stamer UM, Stuber F, Muders T, Musshoff F. Respiratory depression with tramadol in a patient with renal impairment and CYP2D6 gene duplication. Anesth Analg. 2008;107:926–929.
   PubMed Web of Science ®Google Scholar
• Bunten H, Liang WJ, Pounder DJ, Seneviratne C, Osselton D. OPRM1 and CYP2B6 gene variants as risk factors in methadone-related deaths. Clin Pharmacol Ther. 2010;88:383–389.
   PubMed Web of Science ®Google Scholar
• Pharmacology Weekly. What genetic polymorphisms of the CYP3A4 enzyme have the potential to influence drug efficacy and/or safety? Pharmacology Weekly. 2011. Available at: http://www.pharmacologyweekly.com/articles/genetic-polymorphisms-cytochrome-P450-CYP3A4-enzyme. Accessed May 5, 2015.
   Google Scholar
• Pharmacology Weekly. What are common genetic polymorhpisms to cytochrome P450) (CYP) 2D6 that could impact drug metabolism? Pharmacology Weekly. 2010. Available at: http://www.pharmacologyweekly.com/articles/genetic-polymorphism-CYP-P450-2D6-drug-metabolism. Accessed May 5, 2015.
   Google Scholar
• Zhou SF. Polymorphism of human cytochrome P450 2D6 and its clinical significance: part I. Clin Pharmacokinet. 2009;48:689–723.
   PubMed Web of Science ®Google Scholar
• Zhou SF. Polymorphism of human cytochrome P450 2D6 and its clinical significance: part II. Clin Pharmacokinet. 2009;48:761–804.
   PubMed Web of Science ®Google Scholar
• Zhou SF, Liu JP, Chowbay B. Polymorphism of human cytochrome P450 enzymes and its clinical impact. Drug Metab Rev. 2009;41:89–295.
   PubMed Web of Science ®Google Scholar
• Benowitz NL, Peng M, Jacob P 3rd. Effects of cigarette smoking and carbon monoxide on chlorzoxazone and caffeine metabolism. Clin Pharmacol Ther. 2003;74:468–474.
   PubMed Web of Science ®Google Scholar
• Hukkanen J, Jacob P 3rd, Peng M, Dempsey D, Benowitz NL. Effect of nicotine on cytochrome P450 1A2 activity. Br J Clin Pharmacol. 2011;72:836–838.
   PubMed Web of Science ®Google Scholar
• Zevin S, Benowitz NL. Drug interactions with tobacco smoking. An update. Clinical Pharmacokinet. 1999;36:425–438.
   PubMed Web of Science ®Google Scholar
• Wahawisan J, Kolluru S, Nguyen T, Molina C, Speake J. Methadone toxicity due to smoking cessation—a case report on the drug-drug interaction involving cytochrome P450 isoenzyme 1A2. Ann Pharmacother. 2011;45:e34.
   PubMedGoogle Scholar
• Guengerich FP, Kim DH, Iwasaki M. Role of human cytochrome P-450 IIE1 in the oxidation of many low molecular weight cancer suspects. Chem Res Toxicol. 1991;4:168–179.
   PubMed Web of Science ®Google Scholar
• Wrighton SA, Stevens JC. The human hepatic cytochromes P450 involved in drug metabolism. Crit Rev Toxicol. 1992;22:1–21.
   PubMed Web of Science ®Google Scholar
• Benowitz NL, Jacob P 3rd. Nicotine and cotinine elimination pharmacokinetics in smokers and nonsmokers. Clin Pharmacol Ther. 1993;53:316–323.
   PubMed Web of Science ®Google Scholar
• Bock KW, Frohling W, Remmer H, Rexer B. Effects of phenobarbital and 3-methylcholanthrene on substrate specificity of rat liver microsomal UDP-glucuronyltransferase. Biochim Biophys Acta. 1973;327:46–56.
   PubMed Web of Science ®Google Scholar
• Villard PH, Herber R, Seree EM, Attolini L, Magdalou J, Lacarelle B. Effect of cigarette smoke on UDP-glucuronosyltransferase activity and cytochrome P450 content in liver, lung and kidney microsomes in mice. Pharmacol Toxicol. 1998;82:74–79.
   PubMedGoogle Scholar
• Bock KW, Schrenk D, Forster A, et al. The influence of environmental and genetic factors on CYP2D6, CYP1A2 and UDP-glucuronosyltransferases in man using sparteine, caffeine, and paracetamol as probes. Pharmacogenetics. 1994;4:209–218.
   PubMedGoogle Scholar
• Sweeney BP, Grayling M. Smoking and anaesthesia: the pharmacological implications. Anaesthesia. 2009;64:179–186.
   PubMed Web of Science ®Google Scholar
• Leemann T, Bonnabry P, Dayer P. Selective inhibition of major drug metabolizing cytochrome P450 isozymes in human liver microsomes by carbon monoxide. Life Sci. 1994;54:951–956.
   PubMed Web of Science ®Google Scholar
• Alexidis AN, Rekka EA, Kourounakis PN. Influence of mercury and cadmium intoxication on hepatic microsomal CYP2E and CYP3A subfamilies. Res Commun Mol Pathol Pharmacol. 1994;85:67–72.
   PubMed Web of Science ®Google Scholar
• Gourlay DL, Heit HA, Almahrezi A. Universal precautions in pain medicine: a rational approach to the treatment of chronic pain. Pain Med. 2005;6:107–112.
   PubMed Web of Science ®Google Scholar
• Turk DC, Swanson KS, Gatchel RJ. Predicting opioid misuse by chronic pain patients: a systematic review and literature synthesis. Clin J Pain. 2008;24:497–508.
   PubMed Web of Science ®Google Scholar
• Weaver MF, Schnoll SH. Opioid treatment of chronic pain in patients with addiction. J Pain Palliat Care Pharmacother. 2002;16:5–26.
   PubMedGoogle Scholar
• Lai S, Lai H, Page JB, McCoy CB. The association between cigarette smoking and drug abuse in the United States. J Addict Dis. 2000;19:11–24.
   PubMed Web of Science ®Google Scholar
• Rigotti NA, Lee JE, Wechsler H. US college students’ use of tobacco products: results of a national survey. JAMA. 2000;284:699–705.
   PubMed Web of Science ®Google Scholar
• Weaver M, Breland A, Spindle T, Eissenberg T. Electronic cigarettes: a review of safety and clinical issues. J Addict Med. 2014;8:234–240.
   PubMed Web of Science ®Google Scholar
• Eissenberg T. AANA journal course: update for nurse anesthetists—part 3—tobacco smoking using a waterpipe (hookah): what you need to know. AANA J. 2013;81:308–313.
   PubMedGoogle Scholar
• Breland AB, Spindle T, Weaver M, Eissenberg T. Science and electronic cigarettes: current data, future needs. J Addict Med. 2014;8:223–233.
   PubMed Web of Science ®Google Scholar
• Cahn Z, Siegel M. Electronic cigarettes as a harm reduction strategy for tobacco control: a step forward or a repeat of past mistakes? J Public Health Policy. 2011;32:16–31.
   PubMed Web of Science ®Google Scholar
• McQueen A, Tower S, Sumner W. Interviews with “vapers”: implications for future research with electronic cigarettes. Nicotine Tob Res. 2011;13:860–867.
   PubMed Web of Science ®Google Scholar
• Hutzler C, Paschke M, Kruschinski S, Henkler F, Hahn J, Luch A. Chemical hazards present in liquids and vapors of electronic cigarettes. Arch Toxicol. 2014;88:1295–1308.
   PubMed Web of Science ®Google Scholar
• Talih S, Balhas Z, Eissenberg T, et al. Effects of user puff topography, device voltage, and liquid nicotine concentration on electronic cigarette nicotine yield: measurements and model predictions. Nicotine Tob Res. 2015;17:150–157.
   PubMed Web of Science ®Google Scholar
• Tessaro I, Lyna PR, Rimer BK, et al. Readiness to change smoking behavior in a community health center population. J Community Health. 1997;22:15–31.
   PubMed Web of Science ®Google Scholar
• Kreuter MW, Chheda SG, Bull FC. How does physician advice influence patient behavior? Evidence for a priming effect. Arch Fam Med. 2000;9:426–433.
   PubMedGoogle Scholar
• Whitlock EP, Orleans CT, Pender N, Allan J. Evaluating primary care behavioral counseling interventions: an evidence-based approach. Am J Prev Med. 2002;22:267–284.
   PubMed Web of Science ®Google Scholar
• Weaver MF, Jarvis MA, Schnoll SH. Role of the primary care physician in problems of substance abuse. Arch Intern Med. 1999;159:913–924.
   PubMed Web of Science ®Google Scholar
• Stead LF, Bergson G, Lancaster T. Physician advice for smoking cessation. Cochrane Database Syst Rev. 2008;(2):CD000165.
   Google Scholar
• Hughes JR. How confident should we be that smoking cessation treatments work? Addiction. 2009;104:1637–1640.
   PubMed Web of Science ®Google Scholar
• Swan GE, McAfee T, Curry SJ, et al. Effectiveness of bupropion sustained release for smoking cessation in a health care setting: a randomized trial. Arch Intern Med. 2003;163:2337–2344.
   PubMed Web of Science ®Google Scholar
• Semenchuk MR, Sherman S, Davis B. Double-blind, randomized trial of bupropion SR for the treatment of neuropathic pain. Neurology. 2001;57:1583–1588.
   PubMed Web of Science ®Google Scholar
• Lasser K, Boyd JW, Woolhandler S, Himmelstein DU, McCormick D, Bor DH. Smoking and mental illness: a population-based prevalence study. JAMA. 2000;284:2606–2610.
   PubMed Web of Science ®Google Scholar
• Budney AJ, Higgins ST, Hughes JR, Bickel WK. Nicotine and caffeine use in cocaine-dependent individuals. J Subst Abuse. 1993;5:117–130.
   PubMedGoogle Scholar
• Patkar AA, Lundy A, Leone FT, Weinstein SP, Gottheil E, Steinberg M. Tobacco and alcohol use and medical symptoms among cocaine dependent patients. Subst Abus. 2002;23:105–114.
   PubMedGoogle Scholar
• Gorelick DA, Simmons MS, Carriero N, Tashkin DP. Characteristics of smoked drug use among cocaine smokers. Am J Addict. 1997;6:237–245.
   PubMed Web of Science ®Google Scholar
• Patkar AA, Sterling RC, Leone FT, Lundy A, Weinstein SP. Relationship between tobacco smoking and medical symptoms among cocaine-, alcohol-, and opiate-dependent patients. Am J Addict. 2002;11:209–218.
   PubMed Web of Science ®Google Scholar
• Roll JM, Higgins ST, Budney AJ, Bickel WK, Badger GJ. A comparison of cocaine-dependent cigarette smokers and non-smokers on demographic, drug use and other characteristics. Drug Alcohol Depend. 1996;40:195–201.
   PubMed Web of Science ®Google Scholar
• Dawson DA. Drinking as a risk factor for sustained smoking. Drug Alcohol Depend. 2000;59:235–249.
   PubMed Web of Science ®Google Scholar
• Larsson A, Engel JA. Neurochemical and behavioral studies on ethanol and nicotine interactions. Neurosci Biobehav Rev. 2004;27:713–720.
   PubMed Web of Science ®Google Scholar
• Burling TA, Ziff DC. Tobacco smoking: a comparison between alcohol and drug abuse inpatients. Addict Behav. 1988;13:185–190.
   PubMed Web of Science ®Google Scholar
• Crowley TJ, Chesluk D, Dilts S, Hart R. Drug and alcohol abuse among psychiatric admissions. A multidrug clinical-tosicologic study. Arch Gen Psychiatry. 1974;30:13–20.
   PubMed Web of Science ®Google Scholar
• DiFranza JR, Guerrera MP. Alcoholism and smoking. J Stud Alcohol. 1990;51:130–135.
   PubMed Web of Science ®Google Scholar
• Lerner CA, Sundar IK, Watson RM, et al. Environmental health hazards of e-cigarettes and their components: Oxidants and copper in e-cigarette aerosols. Environ Pollut. 2015;198:100–107.
   PubMed Web of Science ®Google Scholar
• Protano C, Di Milia LM, Orsi GB, Vitali M. Electronic cigarette: a threat or an opportunity for public health? State of the art and future perspectives. Clin Ter. 2015;166: 32–37.
   PubMedGoogle Scholar
• Sorensen LT. Wound healing and infection in surgery. The clinical impact of smoking and smoking cessation: a systematic review and meta-analysis. Arch Surg. 2012;147: 373–383.
   PubMed Web of Science ®Google Scholar